id	sid	tid	token	lemma	pos
dpc-504	1	1	dermatology	dermatology	NOUN
dpc-504	1	2	:	:	PUNCT
dpc-504	1	3	practical	practical	ADJ
dpc-504	1	4	and	and	CCONJ
dpc-504	1	5	conceptual	conceptual	ADJ
dpc-504	1	6	340	340	NUM
dpc-504	1	7	letter	letter	NOUN
dpc-504	2	1	|	|	ADV
dpc-504	2	2	dermatol	dermatol	ADJ
dpc-504	2	3	pract	pract	NOUN
dpc-504	2	4	concept	concept	NOUN
dpc-504	2	5	2018;8(4):20	2018;8(4):20	NUM
dpc-504	2	6	dermatology	dermatology	NOUN
dpc-504	2	7	practical	practical	ADJ
dpc-504	2	8	&	&	CCONJ
dpc-504	2	9	conceptual	conceptual	ADJ
dpc-504	2	10	www.derm101.com	www.derm101.com	X
dpc-504	2	11	introduction	introduction	NOUN
dpc-504	2	12	vandetanib	vandetanib	PROPN
dpc-504	2	13	is	be	AUX
dpc-504	2	14	an	an	DET
dpc-504	2	15	oral	oral	ADJ
dpc-504	2	16	tyrosine	tyrosine	NOUN
dpc-504	2	17	kinase	kinase	PROPN
dpc-504	2	18	inhibitor	inhibitor	PROPN
dpc-504	2	19	used	use	VERB
dpc-504	2	20	in	in	ADP
dpc-504	2	21	the	the	DET
dpc-504	2	22	treatment	treatment	NOUN
dpc-504	2	23	of	of	ADP
dpc-504	2	24	different	different	ADJ
dpc-504	2	25	types	type	NOUN
dpc-504	2	26	of	of	ADP
dpc-504	2	27	cancer	cancer	NOUN
dpc-504	2	28	.	.	PUNCT
dpc-504	3	1	it	it	PRON
dpc-504	3	2	acts	act	VERB
dpc-504	3	3	by	by	ADP
dpc-504	3	4	inhibiting	inhibit	VERB
dpc-504	3	5	the	the	DET
dpc-504	3	6	vascular	vascular	ADJ
dpc-504	3	7	and	and	CCONJ
dpc-504	3	8	epidermal	epidermal	ADJ
dpc-504	3	9	growth	growth	NOUN
dpc-504	3	10	factor	factor	NOUN
dpc-504	3	11	receptor	receptor	NOUN
dpc-504	3	12	and	and	CCONJ
dpc-504	3	13	is	be	AUX
dpc-504	3	14	associated	associate	VERB
dpc-504	3	15	with	with	ADP
dpc-504	3	16	frequent	frequent	ADJ
dpc-504	3	17	adverse	adverse	ADJ
dpc-504	3	18	cutaneous	cutaneous	ADJ
dpc-504	3	19	reactions	reaction	NOUN
dpc-504	3	20	such	such	ADJ
dpc-504	3	21	as	as	ADP
dpc-504	3	22	acneiform	acneiform	ADJ
dpc-504	3	23	eruption	eruption	NOUN
dpc-504	3	24	,	,	PUNCT
dpc-504	3	25	photosensitivity	photosensitivity	NOUN
dpc-504	3	26	,	,	PUNCT
dpc-504	3	27	pigmentary	pigmentary	ADJ
dpc-504	3	28	changes	change	NOUN
dpc-504	3	29	,	,	PUNCT
dpc-504	3	30	exanthema	exanthema	NOUN
dpc-504	3	31	,	,	PUNCT
dpc-504	3	32	pruritus	pruritus	NOUN
dpc-504	3	33	,	,	PUNCT
dpc-504	3	34	and	and	CCONJ
dpc-504	3	35	xerosis	xerosis	NOUN
dpc-504	3	36	.	.	PUNCT
dpc-504	4	1	we	we	PRON
dpc-504	4	2	describe	describe	VERB
dpc-504	4	3	an	an	DET
dpc-504	4	4	unusual	unusual	ADJ
dpc-504	4	5	,	,	PUNCT
dpc-504	4	6	peculiar	peculiar	ADJ
dpc-504	4	7	form	form	NOUN
dpc-504	4	8	of	of	ADP
dpc-504	4	9	perifollicular	perifollicular	ADJ
dpc-504	4	10	pigmentation	pigmentation	NOUN
dpc-504	4	11	associated	associate	VERB
dpc-504	4	12	with	with	ADP
dpc-504	4	13	the	the	DET
dpc-504	4	14	use	use	NOUN
dpc-504	4	15	of	of	ADP
dpc-504	4	16	the	the	DET
dpc-504	4	17	drug	drug	NOUN
dpc-504	4	18	and	and	CCONJ
dpc-504	4	19	show	show	VERB
dpc-504	4	20	its	its	PRON
dpc-504	4	21	dermoscopic	dermoscopic	NOUN
dpc-504	4	22	findings	finding	NOUN
dpc-504	4	23	.	.	PUNCT
dpc-504	5	1	case	case	NOUN
dpc-504	5	2	presentation	presentation	NOUN
dpc-504	5	3	a	a	DET
dpc-504	5	4	 	 	SPACE
dpc-504	5	5	26	26	NUM
dpc-504	5	6	-	-	PUNCT
dpc-504	5	7	year	year	NOUN
dpc-504	5	8	-	-	PUNCT
dpc-504	5	9	old	old	ADJ
dpc-504	5	10	male	male	ADJ
dpc-504	5	11	patient	patient	NOUN
dpc-504	5	12	was	be	AUX
dpc-504	5	13	diagnosed	diagnose	VERB
dpc-504	5	14	with	with	ADP
dpc-504	5	15	metastatic	metastatic	ADJ
dpc-504	5	16	medullary	medullary	ADJ
dpc-504	5	17	thyroid	thyroid	NOUN
dpc-504	5	18	carcinoma	carcinoma	NOUN
dpc-504	5	19	.	.	PUNCT
dpc-504	6	1	after	after	ADP
dpc-504	6	2	combined	combine	VERB
dpc-504	6	3	treatment	treatment	NOUN
dpc-504	6	4	with	with	ADP
dpc-504	6	5	surgery	surgery	NOUN
dpc-504	6	6	,	,	PUNCT
dpc-504	6	7	radiotherapy	radiotherapy	NOUN
dpc-504	6	8	,	,	PUNCT
dpc-504	6	9	and	and	CCONJ
dpc-504	6	10	chemotherapy	chemotherapy	NOUN
dpc-504	6	11	,	,	PUNCT
dpc-504	6	12	the	the	DET
dpc-504	6	13	disease	disease	NOUN
dpc-504	6	14	progressed	progress	VERB
dpc-504	6	15	and	and	CCONJ
dpc-504	6	16	vandetanib	vandetanib	NOUN
dpc-504	6	17	was	be	AUX
dpc-504	6	18	started	start	VERB
dpc-504	6	19	.	.	PUNCT
dpc-504	7	1	two	two	NUM
dpc-504	7	2	weeks	week	NOUN
dpc-504	7	3	later	later	ADV
dpc-504	7	4	,	,	PUNCT
dpc-504	7	5	the	the	DET
dpc-504	7	6	patient	patient	NOUN
dpc-504	7	7	developed	develop	VERB
dpc-504	7	8	an	an	DET
dpc-504	7	9	acneiform	acneiform	ADJ
dpc-504	7	10	rash	rash	NOUN
dpc-504	7	11	with	with	ADP
dpc-504	7	12	lesions	lesion	NOUN
dpc-504	7	13	on	on	ADP
dpc-504	7	14	the	the	DET
dpc-504	7	15	trunk	trunk	NOUN
dpc-504	7	16	and	and	CCONJ
dpc-504	7	17	face	face	NOUN
dpc-504	7	18	and	and	CCONJ
dpc-504	7	19	was	be	AUX
dpc-504	7	20	subsequently	subsequently	ADV
dpc-504	7	21	treated	treat	VERB
dpc-504	7	22	with	with	ADP
dpc-504	7	23	doxycycline	doxycycline	NOUN
dpc-504	7	24	 	 	SPACE
dpc-504	7	25	200	200	NUM
dpc-504	7	26	 	 	SPACE
dpc-504	7	27	mg	mg	PROPN
dpc-504	7	28	/	/	SYM
dpc-504	7	29	day	day	NOUN
dpc-504	7	30	for	for	ADP
dpc-504	7	31	 	 	SPACE
dpc-504	7	32	6	6	NUM
dpc-504	7	33	 	 	SPACE
dpc-504	7	34	months	month	NOUN
dpc-504	7	35	with	with	ADP
dpc-504	7	36	improvement	improvement	NOUN
dpc-504	7	37	.	.	PUNCT
dpc-504	8	1	on	on	ADP
dpc-504	8	2	dermatological	dermatological	ADJ
dpc-504	8	3	follow	follow	NOUN
dpc-504	8	4	-	-	PUNCT
dpc-504	8	5	up	up	NOUN
dpc-504	8	6	,	,	PUNCT
dpc-504	8	7	the	the	DET
dpc-504	8	8	patient	patient	NOUN
dpc-504	8	9	was	be	AUX
dpc-504	8	10	still	still	ADV
dpc-504	8	11	taking	take	VERB
dpc-504	8	12	vandetanib	vandetanib	NOUN
dpc-504	8	13	,	,	PUNCT
dpc-504	8	14	with	with	ADP
dpc-504	8	15	clearance	clearance	NOUN
dpc-504	8	16	of	of	ADP
dpc-504	8	17	the	the	DET
dpc-504	8	18	acneiform	acneiform	NOUN
dpc-504	8	19	lesions	lesion	NOUN
dpc-504	8	20	,	,	PUNCT
dpc-504	8	21	but	but	CCONJ
dpc-504	8	22	many	many	ADJ
dpc-504	8	23	pigmented	pigment	VERB
dpc-504	8	24	follicular	follicular	ADJ
dpc-504	8	25	macules	macule	NOUN
dpc-504	8	26	with	with	ADP
dpc-504	8	27	a	a	DET
dpc-504	8	28	comedo	comedo	NOUN
dpc-504	8	29	-	-	PUNCT
dpc-504	8	30	like	like	ADJ
dpc-504	8	31	appearance	appearance	NOUN
dpc-504	8	32	were	be	AUX
dpc-504	8	33	noted	note	VERB
dpc-504	8	34	on	on	ADP
dpc-504	8	35	the	the	DET
dpc-504	8	36	face	face	NOUN
dpc-504	8	37	and	and	CCONJ
dpc-504	8	38	chest	chest	NOUN
dpc-504	8	39	(	(	PUNCT
dpc-504	8	40	figure	figure	NOUN
dpc-504	8	41	 	 	SPACE
dpc-504	8	42	1	1	NUM
dpc-504	8	43	)	)	PUNCT
dpc-504	8	44	.	.	PUNCT
dpc-504	9	1	the	the	DET
dpc-504	9	2	pigmentadermoscopic	pigmentadermoscopic	ADJ
dpc-504	9	3	findings	finding	NOUN
dpc-504	9	4	of	of	ADP
dpc-504	9	5	perifollicular	perifollicular	ADJ
dpc-504	9	6	pigmentation	pigmentation	NOUN
dpc-504	9	7	associated	associate	VERB
dpc-504	9	8	with	with	ADP
dpc-504	9	9	vandetanib	vandetanib	PROPN
dpc-504	9	10	jade	jade	PROPN
dpc-504	9	11	cury	cury	PROPN
dpc-504	9	12	-	-	PUNCT
dpc-504	9	13	martins1	martins1	NOUN
dpc-504	9	14	,	,	PUNCT
dpc-504	9	15	jose	jose	PROPN
dpc-504	9	16	antonio	antonio	PROPN
dpc-504	9	17	sanches1	sanches1	PROPN
dpc-504	9	18	1	1	NUM
dpc-504	9	19	 	 	SPACE
dpc-504	9	20	department	department	NOUN
dpc-504	9	21	of	of	ADP
dpc-504	9	22	dermatology	dermatology	NOUN
dpc-504	9	23	,	,	PUNCT
dpc-504	9	24	university	university	NOUN
dpc-504	9	25	of	of	ADP
dpc-504	9	26	são	são	PROPN
dpc-504	9	27	paulo	paulo	PROPN
dpc-504	9	28	,	,	PUNCT
dpc-504	9	29	são	são	PROPN
dpc-504	9	30	paulo	paulo	PROPN
dpc-504	9	31	,	,	PUNCT
dpc-504	9	32	brazil	brazil	PROPN
dpc-504	9	33	key	key	ADJ
dpc-504	9	34	words	word	NOUN
dpc-504	9	35	:	:	PUNCT
dpc-504	9	36	cutaneous	cutaneous	ADJ
dpc-504	9	37	adverse	adverse	ADJ
dpc-504	9	38	events	event	NOUN
dpc-504	9	39	,	,	PUNCT
dpc-504	9	40	tyrosine	tyrosine	NOUN
dpc-504	9	41	kinase	kinase	PROPN
dpc-504	9	42	inhibitor	inhibitor	PROPN
dpc-504	9	43	,	,	PUNCT
dpc-504	9	44	pigmentation	pigmentation	NOUN
dpc-504	9	45	,	,	PUNCT
dpc-504	9	46	dermoscopy	dermoscopy	VERB
dpc-504	9	47	citation	citation	NOUN
dpc-504	9	48	:	:	PUNCT
dpc-504	9	49	cury	cury	NOUN
dpc-504	9	50	-	-	PUNCT
dpc-504	9	51	martins	martin	NOUN
dpc-504	9	52	j	j	PROPN
dpc-504	9	53	,	,	PUNCT
dpc-504	9	54	sanches	sanches	PROPN
dpc-504	9	55	ja	ja	PROPN
dpc-504	9	56	.	.	PROPN
dpc-504	9	57	dermoscopic	dermoscopic	PROPN
dpc-504	9	58	findings	finding	NOUN
dpc-504	9	59	of	of	ADP
dpc-504	9	60	perifollicular	perifollicular	ADJ
dpc-504	9	61	pigmentation	pigmentation	NOUN
dpc-504	9	62	associated	associate	VERB
dpc-504	9	63	with	with	ADP
dpc-504	9	64	vandetanib	vandetanib	PROPN
dpc-504	9	65	.	.	PUNCT
dpc-504	10	1	dermatol	dermatol	NOUN
dpc-504	10	2	pract	pract	PROPN
dpc-504	10	3	concept	concept	NOUN
dpc-504	10	4	.	.	PUNCT
dpc-504	11	1	2018;8(4):340	2018;8(4):340	NUM
dpc-504	11	2	-	-	SYM
dpc-504	11	3	341	341	NUM
dpc-504	11	4	.	.	PUNCT
dpc-504	11	5	doi	doi	NOUN
dpc-504	11	6	:	:	PUNCT
dpc-504	11	7	https://doi.org/10.5826/dpc.0804a20	https://doi.org/10.5826/dpc.0804a20	PROPN
dpc-504	11	8	received	receive	VERB
dpc-504	11	9	:	:	PUNCT
dpc-504	11	10	march	march	PROPN
dpc-504	11	11	 	 	SPACE
dpc-504	11	12	28	28	NUM
dpc-504	11	13	,	,	PUNCT
dpc-504	11	14	2018	2018	NUM
dpc-504	11	15	;	;	PUNCT
dpc-504	11	16	accepted	accept	VERB
dpc-504	11	17	:	:	PUNCT
dpc-504	11	18	may	may	AUX
dpc-504	11	19	 	 	SPACE
dpc-504	11	20	7	7	NUM
dpc-504	11	21	,	,	PUNCT
dpc-504	11	22	2018	2018	NUM
dpc-504	11	23	;	;	PUNCT
dpc-504	11	24	published	publish	VERB
dpc-504	11	25	:	:	PUNCT
dpc-504	11	26	october	october	PROPN
dpc-504	11	27	 	 	SPACE
dpc-504	11	28	31	31	NUM
dpc-504	11	29	,	,	PUNCT
dpc-504	11	30	2018	2018	NUM
dpc-504	11	31	copyright	copyright	NOUN
dpc-504	11	32	:	:	PUNCT
dpc-504	11	33	©	©	PROPN
dpc-504	11	34	2018	2018	NUM
dpc-504	11	35	 	 	SPACE
dpc-504	11	36	cury	cury	NOUN
dpc-504	11	37	-	-	PUNCT
dpc-504	11	38	martins	martin	NOUN
dpc-504	11	39	et	et	NOUN
dpc-504	11	40	 	 	SPACE
dpc-504	11	41	al	al	PROPN
dpc-504	11	42	.	.	PUNCT
dpc-504	12	1	this	this	PRON
dpc-504	12	2	is	be	AUX
dpc-504	12	3	an	an	DET
dpc-504	12	4	open	open	ADJ
dpc-504	12	5	-	-	PUNCT
dpc-504	12	6	access	access	NOUN
dpc-504	12	7	article	article	NOUN
dpc-504	12	8	distributed	distribute	VERB
dpc-504	12	9	under	under	ADP
dpc-504	12	10	the	the	DET
dpc-504	12	11	terms	term	NOUN
dpc-504	12	12	of	of	ADP
dpc-504	12	13	the	the	DET
dpc-504	12	14	creative	creative	ADJ
dpc-504	12	15	commons	common	NOUN
dpc-504	12	16	attribution	attribution	NOUN
dpc-504	12	17	license	license	NOUN
dpc-504	12	18	,	,	PUNCT
dpc-504	12	19	which	which	PRON
dpc-504	12	20	permits	permit	VERB
dpc-504	12	21	unrestricted	unrestricted	ADJ
dpc-504	12	22	use	use	NOUN
dpc-504	12	23	,	,	PUNCT
dpc-504	12	24	distribution	distribution	NOUN
dpc-504	12	25	,	,	PUNCT
dpc-504	12	26	and	and	CCONJ
dpc-504	12	27	reproduction	reproduction	NOUN
dpc-504	12	28	in	in	ADP
dpc-504	12	29	any	any	DET
dpc-504	12	30	medium	medium	NOUN
dpc-504	12	31	,	,	PUNCT
dpc-504	12	32	provided	provide	VERB
dpc-504	12	33	the	the	DET
dpc-504	12	34	original	original	ADJ
dpc-504	12	35	author	author	NOUN
dpc-504	12	36	and	and	CCONJ
dpc-504	12	37	source	source	NOUN
dpc-504	12	38	are	be	AUX
dpc-504	12	39	credited	credit	VERB
dpc-504	12	40	.	.	PUNCT
dpc-504	13	1	funding	funding	NOUN
dpc-504	13	2	:	:	PUNCT
dpc-504	13	3	none	none	NOUN
dpc-504	13	4	.	.	PUNCT
dpc-504	14	1	competing	compete	VERB
dpc-504	14	2	interests	interest	NOUN
dpc-504	14	3	:	:	PUNCT
dpc-504	14	4	the	the	DET
dpc-504	14	5	authors	author	NOUN
dpc-504	14	6	have	have	VERB
dpc-504	14	7	no	no	DET
dpc-504	14	8	conflicts	conflict	NOUN
dpc-504	14	9	of	of	ADP
dpc-504	14	10	interest	interest	NOUN
dpc-504	14	11	to	to	PART
dpc-504	14	12	disclose	disclose	VERB
dpc-504	14	13	.	.	PUNCT
dpc-504	15	1	all	all	DET
dpc-504	15	2	authors	author	NOUN
dpc-504	15	3	have	have	AUX
dpc-504	15	4	contributed	contribute	VERB
dpc-504	15	5	significantly	significantly	ADV
dpc-504	15	6	to	to	ADP
dpc-504	15	7	this	this	DET
dpc-504	15	8	publication	publication	NOUN
dpc-504	15	9	.	.	PUNCT
dpc-504	16	1	corresponding	correspond	VERB
dpc-504	16	2	author	author	NOUN
dpc-504	16	3	:	:	PUNCT
dpc-504	16	4	jade	jade	PROPN
dpc-504	16	5	cury	cury	PROPN
dpc-504	16	6	-	-	PUNCT
dpc-504	16	7	martins	martin	NOUN
dpc-504	16	8	,	,	PUNCT
dpc-504	16	9	md	md	PROPN
dpc-504	16	10	,	,	PUNCT
dpc-504	16	11	phd	phd	PROPN
dpc-504	16	12	.	.	PROPN
dpc-504	16	13	email	email	PROPN
dpc-504	16	14	:	:	PUNCT
dpc-504	16	15	jadecury@yahoo.com.br	jadecury@yahoo.com.br	PROPN
dpc-504	16	16	figure	figure	NOUN
dpc-504	16	17	  	  	SPACE
dpc-504	16	18	1	1	NUM
dpc-504	16	19	.	.	PUNCT
dpc-504	16	20	pigmented	pigment	VERB
dpc-504	16	21	follicular	follicular	ADJ
dpc-504	16	22	macules	macule	NOUN
dpc-504	16	23	with	with	ADP
dpc-504	16	24	comedo	comedo	NOUN
dpc-504	16	25	-	-	PUNCT
dpc-504	16	26	like	like	ADJ
dpc-504	16	27	appearance	appearance	NOUN
dpc-504	16	28	on	on	ADP
dpc-504	16	29	the	the	DET
dpc-504	16	30	face	face	NOUN
dpc-504	16	31	.	.	PUNCT
dpc-504	17	1	[	[	X
dpc-504	17	2	copyright	copyright	NOUN
dpc-504	17	3	:	:	PUNCT
dpc-504	17	4	©	©	PROPN
dpc-504	17	5	2018	2018	NUM
dpc-504	17	6	 	 	SPACE
dpc-504	17	7	cury	cury	NOUN
dpc-504	17	8	-	-	PUNCT
dpc-504	17	9	martins	martin	NOUN
dpc-504	17	10	et	et	NOUN
dpc-504	17	11	 	 	SPACE
dpc-504	17	12	al	al	PROPN
dpc-504	17	13	.	.	PROPN
dpc-504	17	14	]	]	PUNCT
dpc-504	17	15	letter	letter	NOUN
dpc-504	18	1	|	|	INTJ
dpc-504	18	2	dermatol	dermatol	ADJ
dpc-504	18	3	pract	pract	NOUN
dpc-504	18	4	concept	concept	NOUN
dpc-504	18	5	2018;8(4):20	2018;8(4):20	NUM
dpc-504	18	6	341	341	NUM
dpc-504	18	7	the	the	DET
dpc-504	18	8	use	use	NOUN
dpc-504	18	9	of	of	ADP
dpc-504	18	10	photoprotective	photoprotective	ADJ
dpc-504	18	11	measures	measure	NOUN
dpc-504	18	12	prevented	prevent	VERB
dpc-504	18	13	worsening	worsen	VERB
dpc-504	18	14	of	of	ADP
dpc-504	18	15	the	the	DET
dpc-504	18	16	condition	condition	NOUN
dpc-504	18	17	,	,	PUNCT
dpc-504	18	18	[	[	X
dpc-504	18	19	1	1	NUM
dpc-504	18	20	]	]	PUNCT
dpc-504	18	21	.	.	PUNCT
dpc-504	19	1	conclusion	conclusion	NOUN
dpc-504	19	2	in	in	ADP
dpc-504	19	3	conclusion	conclusion	NOUN
dpc-504	19	4	,	,	PUNCT
dpc-504	19	5	we	we	PRON
dpc-504	19	6	report	report	VERB
dpc-504	19	7	the	the	DET
dpc-504	19	8	first	first	ADJ
dpc-504	19	9	description	description	NOUN
dpc-504	19	10	of	of	ADP
dpc-504	19	11	dermoscopic	dermoscopic	ADJ
dpc-504	19	12	findings	finding	NOUN
dpc-504	19	13	of	of	ADP
dpc-504	19	14	this	this	DET
dpc-504	19	15	rare	rare	ADJ
dpc-504	19	16	pattern	pattern	NOUN
dpc-504	19	17	of	of	ADP
dpc-504	19	18	perifollicular	perifollicular	ADJ
dpc-504	19	19	pigmentation	pigmentation	NOUN
dpc-504	19	20	associated	associate	VERB
dpc-504	19	21	with	with	ADP
dpc-504	19	22	vandetanib	vandetanib	NOUN
dpc-504	19	23	use	use	NOUN
dpc-504	19	24	.	.	PUNCT
dpc-504	20	1	as	as	SCONJ
dpc-504	20	2	oncodermatology	oncodermatology	NOUN
dpc-504	20	3	is	be	AUX
dpc-504	20	4	involved	involve	VERB
dpc-504	20	5	in	in	ADP
dpc-504	20	6	the	the	DET
dpc-504	20	7	supportive	supportive	ADJ
dpc-504	20	8	care	care	NOUN
dpc-504	20	9	of	of	ADP
dpc-504	20	10	cancer	cancer	NOUN
dpc-504	20	11	patients	patient	NOUN
dpc-504	20	12	,	,	PUNCT
dpc-504	20	13	it	it	PRON
dpc-504	20	14	is	be	AUX
dpc-504	20	15	important	important	ADJ
dpc-504	20	16	for	for	SCONJ
dpc-504	20	17	dermatologists	dermatologist	NOUN
dpc-504	20	18	to	to	PART
dpc-504	20	19	identify	identify	VERB
dpc-504	20	20	these	these	DET
dpc-504	20	21	possible	possible	ADJ
dpc-504	20	22	adverse	adverse	ADJ
dpc-504	20	23	events	event	NOUN
dpc-504	20	24	and	and	CCONJ
dpc-504	20	25	use	use	NOUN
dpc-504	20	26	dermoscopy	dermoscopy	NOUN
dpc-504	20	27	as	as	ADP
dpc-504	20	28	an	an	DET
dpc-504	20	29	additional	additional	ADJ
dpc-504	20	30	tool	tool	NOUN
dpc-504	20	31	.	.	PUNCT
dpc-504	21	1	references	reference	NOUN
dpc-504	21	2	1	1	NUM
dpc-504	21	3	.	.	PUNCT
dpc-504	22	1	kong	kong	PROPN
dpc-504	22	2	hh	hh	PROPN
dpc-504	22	3	,	,	PUNCT
dpc-504	22	4	fine	fine	ADJ
dpc-504	22	5	ha	ha	INTJ
dpc-504	22	6	,	,	PUNCT
dpc-504	22	7	stern	stern	PROPN
dpc-504	22	8	jb	jb	PROPN
dpc-504	22	9	,	,	PUNCT
dpc-504	22	10	turner	turner	PROPN
dpc-504	22	11	mlc	mlc	PROPN
dpc-504	22	12	.	.	PUNCT
dpc-504	23	1	cutaneous	cutaneous	ADJ
dpc-504	23	2	pigmentation	pigmentation	NOUN
dpc-504	23	3	following	follow	VERB
dpc-504	23	4	photosensitivity	photosensitivity	NOUN
dpc-504	23	5	induced	induce	VERB
dpc-504	23	6	by	by	ADP
dpc-504	23	7	vandetanib	vandetanib	PROPN
dpc-504	23	8	.	.	PUNCT
dpc-504	24	1	arch	arch	ADJ
dpc-504	24	2	dermatol	dermatol	NOUN
dpc-504	24	3	.	.	PUNCT
dpc-504	25	1	2009;145(8):923	2009;145(8):923	NUM
dpc-504	25	2	-	-	SYM
dpc-504	25	3	925	925	NUM
dpc-504	25	4	.	.	NOUN
dpc-504	26	1	2	2	X
dpc-504	26	2	.	.	X
dpc-504	26	3	giacchero	giacchero	NOUN
dpc-504	26	4	d	d	NOUN
dpc-504	26	5	,	,	PUNCT
dpc-504	26	6	ramacciotti	ramacciotti	PROPN
dpc-504	26	7	c	c	NOUN
dpc-504	26	8	,	,	PUNCT
dpc-504	26	9	arnault	arnault	VERB
dpc-504	26	10	jp	jp	NOUN
dpc-504	26	11	,	,	PUNCT
dpc-504	26	12	et	et	PROPN
dpc-504	26	13	 	 	SPACE
dpc-504	26	14	al	al	PROPN
dpc-504	26	15	.	.	PUNCT
dpc-504	27	1	new	new	ADJ
dpc-504	27	2	spectrum	spectrum	NOUN
dpc-504	27	3	of	of	ADP
dpc-504	27	4	skin	skin	NOUN
dpc-504	27	5	toxic	toxic	ADJ
dpc-504	27	6	effects	effect	NOUN
dpc-504	27	7	associated	associate	VERB
dpc-504	27	8	with	with	ADP
dpc-504	27	9	the	the	DET
dpc-504	27	10	multikinase	multikinase	NOUN
dpc-504	27	11	inhibitor	inhibitor	NOUN
dpc-504	27	12	vandetanib	vandetanib	PROPN
dpc-504	27	13	.	.	PUNCT
dpc-504	28	1	arch	arch	ADJ
dpc-504	28	2	dermatol	dermatol	NOUN
dpc-504	28	3	.	.	PUNCT
dpc-504	29	1	2012;148(12):1418	2012;148(12):1418	NOUN
dpc-504	29	2	-	-	PUNCT
dpc-504	29	3	1420	1420	NUM
dpc-504	29	4	.	.	PUNCT
dpc-504	30	1	tion	tion	NOUN
dpc-504	30	2	was	be	AUX
dpc-504	30	3	apparently	apparently	ADV
dpc-504	30	4	follicular	follicular	ADJ
dpc-504	30	5	;	;	PUNCT
dpc-504	30	6	however	however	ADV
dpc-504	30	7	,	,	PUNCT
dpc-504	30	8	on	on	ADP
dpc-504	30	9	dermoscopy	dermoscopy	NOUN
dpc-504	30	10	,	,	PUNCT
dpc-504	30	11	the	the	DET
dpc-504	30	12	blue	blue	ADJ
dpc-504	30	13	-	-	PUNCT
dpc-504	30	14	gray	gray	ADJ
dpc-504	30	15	pigment	pigment	NOUN
dpc-504	30	16	was	be	AUX
dpc-504	30	17	evident	evident	ADJ
dpc-504	30	18	only	only	ADV
dpc-504	30	19	in	in	ADP
dpc-504	30	20	the	the	DET
dpc-504	30	21	perifollicular	perifollicular	ADJ
dpc-504	30	22	area	area	NOUN
dpc-504	30	23	with	with	ADP
dpc-504	30	24	preservation	preservation	NOUN
dpc-504	30	25	of	of	ADP
dpc-504	30	26	the	the	DET
dpc-504	30	27	center	center	NOUN
dpc-504	30	28	of	of	ADP
dpc-504	30	29	the	the	DET
dpc-504	30	30	hair	hair	NOUN
dpc-504	30	31	follicle	follicle	NOUN
dpc-504	30	32	(	(	PUNCT
dpc-504	30	33	figure	figure	NOUN
dpc-504	30	34	 	 	SPACE
dpc-504	30	35	2	2	NUM
dpc-504	30	36	)	)	PUNCT
dpc-504	30	37	.	.	PUNCT
dpc-504	31	1	after	after	ADP
dpc-504	31	2	orienting	orient	VERB
dpc-504	31	3	the	the	DET
dpc-504	31	4	patient	patient	NOUN
dpc-504	31	5	on	on	ADP
dpc-504	31	6	photoprotective	photoprotective	ADJ
dpc-504	31	7	measures	measure	NOUN
dpc-504	31	8	,	,	PUNCT
dpc-504	31	9	only	only	ADV
dpc-504	31	10	a	a	DET
dpc-504	31	11	little	little	ADJ
dpc-504	31	12	improvement	improvement	NOUN
dpc-504	31	13	was	be	AUX
dpc-504	31	14	noted	note	VERB
dpc-504	31	15	.	.	PUNCT
dpc-504	32	1	one	one	NUM
dpc-504	32	2	year	year	NOUN
dpc-504	32	3	later	later	ADV
dpc-504	32	4	,	,	PUNCT
dpc-504	32	5	the	the	DET
dpc-504	32	6	patient	patient	NOUN
dpc-504	32	7	had	have	VERB
dpc-504	32	8	complete	complete	ADJ
dpc-504	32	9	clearing	clearing	NOUN
dpc-504	32	10	,	,	PUNCT
dpc-504	32	11	despite	despite	SCONJ
dpc-504	32	12	the	the	DET
dpc-504	32	13	continuous	continuous	ADJ
dpc-504	32	14	use	use	NOUN
dpc-504	32	15	of	of	ADP
dpc-504	32	16	vandetanib	vandetanib	PROPN
dpc-504	32	17	.	.	PUNCT
dpc-504	33	1	discussion	discussion	NOUN
dpc-504	33	2	among	among	ADP
dpc-504	33	3	the	the	DET
dpc-504	33	4	pigmentary	pigmentary	ADJ
dpc-504	33	5	changes	change	NOUN
dpc-504	33	6	associated	associate	VERB
dpc-504	33	7	with	with	ADP
dpc-504	33	8	vandetanib	vandetanib	NOUN
dpc-504	33	9	therapy	therapy	NOUN
dpc-504	33	10	,	,	PUNCT
dpc-504	33	11	diffuse	diffuse	ADJ
dpc-504	33	12	pigmentation	pigmentation	NOUN
dpc-504	33	13	in	in	ADP
dpc-504	33	14	the	the	DET
dpc-504	33	15	exposed	expose	VERB
dpc-504	33	16	area	area	NOUN
dpc-504	33	17	is	be	AUX
dpc-504	33	18	the	the	DET
dpc-504	33	19	most	most	ADV
dpc-504	33	20	reported	report	VERB
dpc-504	33	21	form	form	NOUN
dpc-504	33	22	.	.	PUNCT
dpc-504	34	1	the	the	DET
dpc-504	34	2	blue	blue	ADJ
dpc-504	34	3	-	-	PUNCT
dpc-504	34	4	gray	gray	ADJ
dpc-504	34	5	perifollicular	perifollicular	ADJ
dpc-504	34	6	pigmentation	pigmentation	NOUN
dpc-504	34	7	was	be	AUX
dpc-504	34	8	rarely	rarely	ADV
dpc-504	34	9	reported	report	VERB
dpc-504	34	10	,	,	PUNCT
dpc-504	34	11	and	and	CCONJ
dpc-504	34	12	there	there	PRON
dpc-504	34	13	are	be	VERB
dpc-504	34	14	no	no	DET
dpc-504	34	15	similar	similar	ADJ
dpc-504	34	16	reports	report	NOUN
dpc-504	34	17	of	of	ADP
dpc-504	34	18	it	it	PRON
dpc-504	34	19	with	with	ADP
dpc-504	34	20	other	other	ADJ
dpc-504	34	21	agents	agent	NOUN
dpc-504	34	22	of	of	ADP
dpc-504	34	23	the	the	DET
dpc-504	34	24	same	same	ADJ
dpc-504	34	25	class	class	NOUN
dpc-504	34	26	.	.	PUNCT
dpc-504	35	1	this	this	PRON
dpc-504	35	2	seems	seem	VERB
dpc-504	35	3	to	to	PART
dpc-504	35	4	be	be	AUX
dpc-504	35	5	specifically	specifically	ADV
dpc-504	35	6	caused	cause	VERB
dpc-504	35	7	by	by	ADP
dpc-504	35	8	this	this	DET
dpc-504	35	9	medication	medication	NOUN
dpc-504	35	10	.	.	PUNCT
dpc-504	36	1	the	the	DET
dpc-504	36	2	pathogenesis	pathogenesis	NOUN
dpc-504	36	3	of	of	ADP
dpc-504	36	4	this	this	DET
dpc-504	36	5	peculiar	peculiar	ADJ
dpc-504	36	6	pattern	pattern	NOUN
dpc-504	36	7	of	of	ADP
dpc-504	36	8	pigmentation	pigmentation	NOUN
dpc-504	36	9	is	be	AUX
dpc-504	36	10	not	not	PART
dpc-504	36	11	well	well	ADV
dpc-504	36	12	established	establish	VERB
dpc-504	36	13	.	.	PUNCT
dpc-504	37	1	previous	previous	ADJ
dpc-504	37	2	reports	report	NOUN
dpc-504	37	3	have	have	AUX
dpc-504	37	4	demonstrated	demonstrate	VERB
dpc-504	37	5	the	the	DET
dpc-504	37	6	histopathological	histopathological	ADJ
dpc-504	37	7	alterations	alteration	NOUN
dpc-504	37	8	in	in	ADP
dpc-504	37	9	a	a	DET
dpc-504	37	10	few	few	ADJ
dpc-504	37	11	similar	similar	ADJ
dpc-504	37	12	cases	case	NOUN
dpc-504	37	13	revealing	reveal	VERB
dpc-504	37	14	dermal	dermal	NOUN
dpc-504	37	15	iron	iron	NOUN
dpc-504	37	16	and	and	CCONJ
dpc-504	37	17	melanin	melanin	NOUN
dpc-504	37	18	deposition	deposition	NOUN
dpc-504	37	19	.	.	PUNCT
dpc-504	38	1	the	the	DET
dpc-504	38	2	presence	presence	NOUN
dpc-504	38	3	of	of	ADP
dpc-504	38	4	pigmented	pigment	VERB
dpc-504	38	5	macrophages	macrophage	NOUN
dpc-504	38	6	and	and	CCONJ
dpc-504	38	7	inflammatory	inflammatory	ADJ
dpc-504	38	8	infiltrate	infiltrate	VERB
dpc-504	38	9	in	in	ADP
dpc-504	38	10	the	the	DET
dpc-504	38	11	dermis	dermis	NOUN
dpc-504	38	12	was	be	AUX
dpc-504	38	13	also	also	ADV
dpc-504	38	14	documented	document	VERB
dpc-504	38	15	[	[	X
dpc-504	38	16	1	1	NUM
dpc-504	38	17	]	]	PUNCT
dpc-504	38	18	.	.	PUNCT
dpc-504	39	1	those	those	DET
dpc-504	39	2	findings	finding	NOUN
dpc-504	39	3	correlate	correlate	VERB
dpc-504	39	4	with	with	ADP
dpc-504	39	5	the	the	DET
dpc-504	39	6	dermoscopy	dermoscopy	NOUN
dpc-504	39	7	,	,	PUNCT
dpc-504	39	8	with	with	ADP
dpc-504	39	9	the	the	DET
dpc-504	39	10	blue	blue	ADJ
dpc-504	39	11	-	-	PUNCT
dpc-504	39	12	gray	gray	ADJ
dpc-504	39	13	pigmentation	pigmentation	NOUN
dpc-504	39	14	corresponding	correspond	VERB
dpc-504	39	15	to	to	ADP
dpc-504	39	16	the	the	DET
dpc-504	39	17	presence	presence	NOUN
dpc-504	39	18	of	of	ADP
dpc-504	39	19	dermal	dermal	ADJ
dpc-504	39	20	pigment	pigment	NOUN
dpc-504	39	21	.	.	PUNCT
dpc-504	40	1	the	the	DET
dpc-504	40	2	previous	previous	ADJ
dpc-504	40	3	use	use	NOUN
dpc-504	40	4	of	of	ADP
dpc-504	40	5	doxycycline	doxycycline	NOUN
dpc-504	40	6	did	do	AUX
dpc-504	40	7	not	not	PART
dpc-504	40	8	seem	seem	VERB
dpc-504	40	9	to	to	PART
dpc-504	40	10	factor	factor	VERB
dpc-504	40	11	into	into	ADP
dpc-504	40	12	the	the	DET
dpc-504	40	13	etiology	etiology	NOUN
dpc-504	40	14	of	of	ADP
dpc-504	40	15	this	this	DET
dpc-504	40	16	condition	condition	NOUN
dpc-504	40	17	.	.	PUNCT
dpc-504	41	1	giacchero	giacchero	PROPN
dpc-504	41	2	et	et	PROPN
dpc-504	41	3	 	 	SPACE
dpc-504	41	4	al	al	PROPN
dpc-504	42	1	[	[	X
dpc-504	42	2	2	2	NUM
dpc-504	42	3	]	]	PUNCT
dpc-504	42	4	showed	show	VERB
dpc-504	42	5	that	that	SCONJ
dpc-504	42	6	less	less	ADJ
dpc-504	42	7	than	than	ADP
dpc-504	42	8	half	half	NOUN
dpc-504	42	9	of	of	ADP
dpc-504	42	10	the	the	DET
dpc-504	42	11	patients	patient	NOUN
dpc-504	42	12	in	in	ADP
dpc-504	42	13	their	their	PRON
dpc-504	42	14	series	series	NOUN
dpc-504	42	15	were	be	AUX
dpc-504	42	16	treated	treat	VERB
dpc-504	42	17	with	with	ADP
dpc-504	42	18	this	this	DET
dpc-504	42	19	medication	medication	NOUN
dpc-504	42	20	.	.	PUNCT
dpc-504	43	1	prior	prior	ADJ
dpc-504	43	2	photosensitivity	photosensitivity	NOUN
dpc-504	43	3	preceding	precede	VERB
dpc-504	43	4	the	the	DET
dpc-504	43	5	pigmentation	pigmentation	NOUN
dpc-504	43	6	was	be	AUX
dpc-504	43	7	described	describe	VERB
dpc-504	43	8	in	in	ADP
dpc-504	43	9	two	two	NUM
dpc-504	43	10	cases	case	NOUN
dpc-504	43	11	[	[	X
dpc-504	43	12	1	1	NUM
dpc-504	43	13	]	]	PUNCT
dpc-504	43	14	.	.	PUNCT
dpc-504	44	1	definitive	definitive	ADJ
dpc-504	44	2	treatment	treatment	NOUN
dpc-504	44	3	of	of	ADP
dpc-504	44	4	the	the	DET
dpc-504	44	5	lesions	lesion	NOUN
dpc-504	44	6	involves	involve	VERB
dpc-504	44	7	stopping	stop	VERB
dpc-504	44	8	the	the	DET
dpc-504	44	9	use	use	NOUN
dpc-504	44	10	of	of	ADP
dpc-504	44	11	vandetanib	vandetanib	NOUN
dpc-504	44	12	followed	follow	VERB
dpc-504	44	13	by	by	ADP
dpc-504	44	14	improvement	improvement	NOUN
dpc-504	44	15	after	after	ADP
dpc-504	44	16	 	 	SPACE
dpc-504	44	17	3–6	3–6	NUM
dpc-504	44	18	 	 	SPACE
dpc-504	44	19	months	month	NOUN
dpc-504	44	20	.	.	PUNCT
dpc-504	45	1	however	however	ADV
dpc-504	45	2	,	,	PUNCT
dpc-504	45	3	recurrence	recurrence	NOUN
dpc-504	45	4	occurs	occur	VERB
dpc-504	45	5	if	if	SCONJ
dpc-504	45	6	the	the	DET
dpc-504	45	7	medication	medication	NOUN
dpc-504	45	8	is	be	AUX
dpc-504	45	9	reintroduced	reintroduce	VERB
dpc-504	45	10	[	[	PUNCT
dpc-504	45	11	2	2	NUM
dpc-504	45	12	]	]	PUNCT
dpc-504	45	13	.	.	PUNCT
dpc-504	46	1	the	the	DET
dpc-504	46	2	use	use	NOUN
dpc-504	46	3	of	of	ADP
dpc-504	46	4	topical	topical	ADJ
dpc-504	46	5	depigmentation	depigmentation	NOUN
dpc-504	46	6	agents	agent	NOUN
dpc-504	46	7	such	such	ADJ
dpc-504	46	8	as	as	ADP
dpc-504	46	9	the	the	DET
dpc-504	46	10	combination	combination	NOUN
dpc-504	46	11	of	of	ADP
dpc-504	46	12	hydroquinone	hydroquinone	NOUN
dpc-504	46	13	,	,	PUNCT
dpc-504	46	14	tretinoin	tretinoin	NOUN
dpc-504	46	15	,	,	PUNCT
dpc-504	46	16	and	and	CCONJ
dpc-504	46	17	corticosteroids	corticosteroid	NOUN
dpc-504	46	18	did	do	AUX
dpc-504	46	19	not	not	PART
dpc-504	46	20	show	show	VERB
dpc-504	46	21	benefits	benefit	NOUN
dpc-504	46	22	[	[	X
dpc-504	46	23	1	1	NUM
dpc-504	46	24	]	]	PUNCT
dpc-504	46	25	.	.	PUNCT
dpc-504	47	1	in	in	ADP
dpc-504	47	2	a	a	DET
dpc-504	47	3	few	few	ADJ
dpc-504	47	4	cases	case	NOUN
dpc-504	47	5	,	,	PUNCT
dpc-504	47	6	figure	figure	NOUN
dpc-504	47	7	 	 	SPACE
dpc-504	47	8	2	2	NUM
dpc-504	47	9	.	.	PUNCT
dpc-504	47	10	on	on	ADP
dpc-504	47	11	dermoscopy	dermoscopy	NOUN
dpc-504	47	12	,	,	PUNCT
dpc-504	47	13	the	the	DET
dpc-504	47	14	blue	blue	ADJ
dpc-504	47	15	-	-	PUNCT
dpc-504	47	16	gray	gray	ADJ
dpc-504	47	17	pigment	pigment	NOUN
dpc-504	47	18	is	be	AUX
dpc-504	47	19	evident	evident	ADJ
dpc-504	47	20	only	only	ADV
dpc-504	47	21	on	on	ADP
dpc-504	47	22	the	the	DET
dpc-504	47	23	perifollicular	perifollicular	ADJ
dpc-504	47	24	area	area	NOUN
dpc-504	47	25	.	.	PUNCT
dpc-504	48	1	[	[	X
dpc-504	48	2	copyright	copyright	NOUN
dpc-504	48	3	:	:	PUNCT
dpc-504	48	4	©	©	PROPN
dpc-504	48	5	2018	2018	NUM
dpc-504	48	6	 	 	SPACE
dpc-504	48	7	cury	cury	NOUN
dpc-504	48	8	-	-	PUNCT
dpc-504	48	9	martins	martin	NOUN
dpc-504	48	10	et	et	NOUN
dpc-504	48	11	 	 	SPACE
dpc-504	48	12	al	al	PROPN
dpc-504	48	13	.	.	PROPN
dpc-504	48	14	]	]	PUNCT